Our mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy. Applications of our current product portfolio include deep-brain stimulation, laser ablation, biopsy, neuro-aspiration, and delivery of drugs, biologics and gene therapy to the brain. The ClearPoint® Neuro Navigation System has FDA clearance, is CE-marked, and is installed in 60+ Clinical & Research Centers in the US, Canada, & EU... and growing globally. ClearPoint Neuro’s SmartFlow® cannula is being used in partnership or evaluation with 30+ individual biologics and drug delivery companies in various stages, from preclinical research to late stage regulatory trials. To date, more than 4,000 cases have been performed and supported by our field-based Clinical Specialist team which offers support and services for our partners.
Location: United States, California, Solana Beach
Employees: 51-200
Founded date: 1998
Investors 2
| Date | Name | Website |
| - | HCL Capita... | hcl-capita... |
| 12.07.2023 | Johns Hopk... | ventures.j... |
Mentions in press and media 20
| Date | Title | Description |
| 04.08.2026 | The Subscription Period in Clinical Laserthermia Systems AB’ Rights Issue of Units Begins Today | The Subscription Period in Clinical Laserthermia Systems AB’ Rights Issue of Units Begins Today Tue, Aug 04, 2026 08:30 CET Report this content NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UN... |
| 27.05.2026 | ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint | Announcement is made after successful proof-of-concept trial in a preclinical model of intravenous delivery of large molecule tracers across the blood-brain barrier guided by prototype systems, including both focused ultrasound hardware and... |
| 07.10.2025 | CLS-sponsored neuro LITT study in patients with malignant brain tumor shows positive results | CLS-sponsored neuro LITT study in patients with malignant brain tumor shows positive results Tue, Oct 07, 2025 22:15 CET Report this content Lund, Sweden, October 7th, 2025 – Clinical Laserthermia Systems AB (publ) (“CLS”) today announces p... |
| 04.09.2025 | Clinical Laserthermia Systems Receives FDA Clearance for Expanded Labeling of the ClearPoint Prism[®] Neuro Laser Therapy System, doubling the addressable U.S market for Neuro LITT | Clinical Laserthermia Systems Receives FDA Clearance for Expanded Labeling of the ClearPoint Prism[®] Neuro Laser Therapy System, doubling the addressable U.S market for Neuro LITT Thu, Sep 04, 2025 17:00 CET Report this content Lund, Swede... |
| 22.08.2025 | CLS publishes half-year report January – June 2025 | CLS publishes half-year report January – June 2025 Fri, Aug 22, 2025 08:30 CET Report this content Lund, Sweden – Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its half year report Janu... |
| 18.06.2025 | The Dawn of Radioligand Therapies: A New Era in Precision Oncology | In the realm of cancer treatment, innovation is the lifeblood that fuels hope. The latest beacon of this hope shines brightly on radioligand therapies (RLTs). These therapies are not just a whisper of potential; they are a clarion call for ... |
| 13.06.2025 | Indianapolis-based startup leans on connections to treat brain diseases | Please subscribe to IBJ to decode this article. so" co7tniifn:wct=l l5m=/nne4bBc_omtI"/ioaedel"-_oii=ii0-edidC5a2ru["00-mca5ae=fud othmtwi1ga"e"3r"daletl0ca]nsene d vy.sdstiheip =loto jee6teo mpts m3t [c6i... |
| 27.02.2025 | Clinical Laserthermia Systems AB raises up to SEK 37m through a directed issue for accelerated commercialization and expansion | Clinical Laserthermia Systems AB raises up to SEK 37m through a directed issue for accelerated commercialization and expansion Thu, Feb 27, 2025 08:55 CET Report this content NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY O... |
| 21.02.2025 | Clinical Laserthermia Systems AB publishes Year-end report January – December 2024 | Clinical Laserthermia Systems AB publishes Year-end report January – December 2024 Fri, Feb 21, 2025 08:30 CET Report this content Summary of the year-end report (relates to the Group) Full year (01/01/2024–12/31/2024) Net sales totaled SEK... |
| 26.08.2024 | ClearPoint Neuro Announces Early Repayment of $10 Million Note | SOLANA BEACH, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that... |
Show more